450 related articles for article (PubMed ID: 25597478)
1. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
[TBL] [Abstract][Full Text] [Related]
2. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
[TBL] [Abstract][Full Text] [Related]
3. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
[TBL] [Abstract][Full Text] [Related]
4. Reliability and validity of the overactive bladder symptom score in Hong Kong Chinese.
Yiu MK; Li CM; Hou SM; Wong CW; Tam S; Chu SK
Hong Kong Med J; 2013 Dec; 19(6):504-10. PubMed ID: 23787257
[TBL] [Abstract][Full Text] [Related]
5. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
[TBL] [Abstract][Full Text] [Related]
6. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response.
Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y
Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study.
Hung MJ; Chou CL; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
J Formos Med Assoc; 2013 May; 112(5):276-82. PubMed ID: 23660224
[TBL] [Abstract][Full Text] [Related]
8. Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom.
Jung HB; Choi DK; Lee SH; Cho ST; Na HR; Park MH
Int Braz J Urol; 2017; 43(2):256-263. PubMed ID: 27802001
[TBL] [Abstract][Full Text] [Related]
9. Reliability of Thai-Version Overactive Bladder Symptom Scores (OABSS) Questionnaire and the Correlations of OABSS with Voiding Diary, International Prostate Symptom Score (IPSS), and Patient Perception of Bladder Condition (PPBC) Questionnaires.
Bunyavejchevin S
J Med Assoc Thai; 2015 Nov; 98(11):1064-74. PubMed ID: 26817176
[TBL] [Abstract][Full Text] [Related]
10. Urge perception index of bladder hypersensitivity.
Fujihara A; Ukimura O; Honjo H; Iwata T; Ueda T; Matsugasumi T; Kamoi K; Okihara K; Kawauchi A; Miki T
J Urol; 2013 May; 189(5):1797-803. PubMed ID: 23201494
[TBL] [Abstract][Full Text] [Related]
11. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
Chung SD; Liao CH; Chen YC; Kuo HC
Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
[TBL] [Abstract][Full Text] [Related]
12. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.
Homma Y; Yoshida M; Seki N; Yokoyama O; Kakizaki H; Gotoh M; Yamanishi T; Yamaguchi O; Takeda M; Nishizawa O
Urology; 2006 Aug; 68(2):318-23. PubMed ID: 16904444
[TBL] [Abstract][Full Text] [Related]
13. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.
Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639
[TBL] [Abstract][Full Text] [Related]
14. Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools.
Sumardi R; Mochtar CA; Junizaf ; Santoso BI; Tjahjodjati ; Purwara BH; Hardjowijoto S; Paraton H; Yunaidi DA
Acta Med Indones; 2012 Jul; 44(3):214-21. PubMed ID: 22983076
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the Overactive Bladder Symptom Score, and the Voiding Diary and Urodynamic Parameters in Patients with Overactive Bladder Syndrome.
Song M; Chun JY; Yoo DS; Han JY; Choo MS
Low Urin Tract Symptoms; 2014 Sep; 6(3):180-4. PubMed ID: 26663602
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness and minimal clinically important change in overactive bladder symptom score.
Gotoh M; Homma Y; Yokoyama O; Nishizawa O
Urology; 2011 Oct; 78(4):768-73. PubMed ID: 21855969
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome.
Panayi DC; Tekkis P; Fernando R; Hendricken C; Khullar V
Neurourol Urodyn; 2010 Sep; 29(7):1295-8. PubMed ID: 20127835
[TBL] [Abstract][Full Text] [Related]
19. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
20. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
